Concepts (204)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Estradiol | 13 | 2002 | 53 | 0.680 |
Why?
|
| Fertilization in Vitro | 11 | 2002 | 13 | 0.640 |
Why?
|
| Chorionic Gonadotropin | 11 | 1995 | 16 | 0.510 |
Why?
|
| Menotropins | 10 | 1996 | 10 | 0.450 |
Why?
|
| Infertility, Female | 9 | 1999 | 22 | 0.400 |
Why?
|
| Pregnancy | 17 | 2001 | 336 | 0.390 |
Why?
|
| Ovarian Follicle | 5 | 2002 | 11 | 0.390 |
Why?
|
| Ovulation Induction | 9 | 2002 | 10 | 0.350 |
Why?
|
| Abortion, Spontaneous | 5 | 1995 | 10 | 0.340 |
Why?
|
| Fallopian Tubes | 5 | 1997 | 9 | 0.330 |
Why?
|
| Follicle Stimulating Hormone | 5 | 2002 | 22 | 0.290 |
Why?
|
| Gonadotropin-Releasing Hormone | 6 | 1995 | 10 | 0.280 |
Why?
|
| Endometriosis | 8 | 1994 | 16 | 0.280 |
Why?
|
| Ovary | 4 | 2002 | 23 | 0.280 |
Why?
|
| Uterus | 2 | 1997 | 17 | 0.260 |
Why?
|
| Progesterone | 10 | 2002 | 20 | 0.250 |
Why?
|
| Autoantibodies | 3 | 2002 | 80 | 0.250 |
Why?
|
| Embryo Transfer | 2 | 1995 | 3 | 0.240 |
Why?
|
| Gonadal Steroid Hormones | 2 | 1996 | 10 | 0.240 |
Why?
|
| Female | 42 | 2021 | 15212 | 0.230 |
Why?
|
| Follicular Fluid | 6 | 2002 | 8 | 0.220 |
Why?
|
| Gamete Intrafallopian Transfer | 3 | 1995 | 3 | 0.220 |
Why?
|
| Sperm Motility | 2 | 1994 | 4 | 0.220 |
Why?
|
| Corpus Luteum | 1 | 2002 | 5 | 0.200 |
Why?
|
| Hyperprolactinemia | 2 | 1995 | 3 | 0.190 |
Why?
|
| Infertility | 2 | 1993 | 8 | 0.180 |
Why?
|
| Prospective Studies | 13 | 1998 | 1778 | 0.170 |
Why?
|
| Fertilization | 4 | 1994 | 5 | 0.170 |
Why?
|
| Embryo, Mammalian | 3 | 1997 | 25 | 0.170 |
Why?
|
| Pregnancy, Multiple | 2 | 1991 | 4 | 0.170 |
Why?
|
| Humans | 40 | 2021 | 27072 | 0.160 |
Why?
|
| Pregnancy Outcome | 3 | 1995 | 20 | 0.160 |
Why?
|
| Blastocyst | 5 | 2001 | 9 | 0.150 |
Why?
|
| Independent Living | 1 | 2021 | 322 | 0.150 |
Why?
|
| Adult | 22 | 2002 | 7831 | 0.140 |
Why?
|
| Zona Pellucida | 1 | 1997 | 1 | 0.140 |
Why?
|
| Sperm Count | 2 | 1994 | 5 | 0.140 |
Why?
|
| Luteal Phase | 2 | 1995 | 5 | 0.140 |
Why?
|
| Ultrasonography | 3 | 1996 | 227 | 0.140 |
Why?
|
| Mutagens | 1 | 1996 | 2 | 0.140 |
Why?
|
| Abnormalities, Drug-Induced | 1 | 1996 | 7 | 0.130 |
Why?
|
| Pregnancy, Ectopic | 2 | 1994 | 4 | 0.130 |
Why?
|
| Quality of Life | 1 | 2021 | 629 | 0.130 |
Why?
|
| Hormones | 4 | 1993 | 15 | 0.120 |
Why?
|
| Ethanol | 1 | 1996 | 86 | 0.120 |
Why?
|
| Chromosome Aberrations | 2 | 1993 | 17 | 0.120 |
Why?
|
| Monitoring, Physiologic | 1 | 1996 | 68 | 0.120 |
Why?
|
| Bacterial Infections | 1 | 1995 | 51 | 0.120 |
Why?
|
| Biopsy, Needle | 1 | 1995 | 105 | 0.120 |
Why?
|
| Bacteria | 1 | 1995 | 70 | 0.120 |
Why?
|
| Ovarian Hyperstimulation Syndrome | 2 | 1992 | 2 | 0.120 |
Why?
|
| Hysterosalpingography | 1 | 1994 | 2 | 0.120 |
Why?
|
| Insemination, Artificial, Homologous | 1 | 1994 | 1 | 0.120 |
Why?
|
| Endometrium | 2 | 1996 | 8 | 0.110 |
Why?
|
| Granulosa Cells | 3 | 2001 | 5 | 0.110 |
Why?
|
| Fetal Heart | 1 | 1993 | 2 | 0.110 |
Why?
|
| Vascular Diseases | 1 | 1993 | 42 | 0.110 |
Why?
|
| Acrosin | 1 | 1993 | 1 | 0.100 |
Why?
|
| Semen | 1 | 1993 | 3 | 0.100 |
Why?
|
| Spermatozoa | 1 | 1993 | 8 | 0.100 |
Why?
|
| Fertility | 1 | 1993 | 18 | 0.100 |
Why?
|
| Danazol | 5 | 1990 | 5 | 0.100 |
Why?
|
| Hypertension | 1 | 1993 | 192 | 0.100 |
Why?
|
| Mice | 6 | 2001 | 1395 | 0.090 |
Why?
|
| Fetal Resorption | 1 | 1991 | 1 | 0.090 |
Why?
|
| Twins | 1 | 1991 | 9 | 0.090 |
Why?
|
| Pituitary Gland | 1 | 1991 | 14 | 0.090 |
Why?
|
| Embryonic and Fetal Development | 4 | 2001 | 10 | 0.090 |
Why?
|
| Leuprolide | 5 | 1995 | 7 | 0.080 |
Why?
|
| Pregnadienes | 4 | 1989 | 4 | 0.080 |
Why?
|
| Pregnancy Trimester, First | 4 | 1993 | 10 | 0.070 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 1988 | 3 | 0.070 |
Why?
|
| Animals | 8 | 2001 | 3642 | 0.070 |
Why?
|
| Prolactin | 1 | 1987 | 4 | 0.070 |
Why?
|
| Male | 8 | 2021 | 14772 | 0.070 |
Why?
|
| Sleep | 1 | 1987 | 328 | 0.060 |
Why?
|
| Vagina | 2 | 1995 | 35 | 0.060 |
Why?
|
| Oocytes | 2 | 1997 | 7 | 0.050 |
Why?
|
| Inhibins | 1 | 2002 | 2 | 0.050 |
Why?
|
| Dehydroepiandrosterone Sulfate | 1 | 2002 | 5 | 0.050 |
Why?
|
| Androstenedione | 1 | 2002 | 6 | 0.050 |
Why?
|
| Lymphokines | 1 | 2002 | 10 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2002 | 15 | 0.050 |
Why?
|
| Endothelial Growth Factors | 1 | 2002 | 11 | 0.050 |
Why?
|
| Drug Resistance | 1 | 2002 | 47 | 0.050 |
Why?
|
| Ultrasonography, Prenatal | 2 | 1993 | 29 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2002 | 75 | 0.050 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2002 | 52 | 0.050 |
Why?
|
| Culture Media | 3 | 1996 | 32 | 0.050 |
Why?
|
| Incidence | 2 | 1995 | 759 | 0.050 |
Why?
|
| Time Factors | 2 | 1997 | 1433 | 0.050 |
Why?
|
| Poland | 1 | 2021 | 2 | 0.050 |
Why?
|
| Receptors, Gonadotropin | 1 | 2001 | 2 | 0.050 |
Why?
|
| Polychlorinated Dibenzodioxins | 1 | 2001 | 1 | 0.050 |
Why?
|
| Environmental Pollutants | 1 | 2001 | 3 | 0.050 |
Why?
|
| Physical Fitness | 1 | 2021 | 51 | 0.050 |
Why?
|
| Apoptosis | 1 | 2001 | 213 | 0.040 |
Why?
|
| Culture Techniques | 2 | 2001 | 21 | 0.040 |
Why?
|
| Ovulation | 2 | 1991 | 3 | 0.040 |
Why?
|
| Pelvic Neoplasms | 2 | 1989 | 7 | 0.040 |
Why?
|
| Menopause, Premature | 1 | 1999 | 7 | 0.040 |
Why?
|
| Primary Ovarian Insufficiency | 1 | 1999 | 8 | 0.040 |
Why?
|
| Coculture Techniques | 2 | 1996 | 29 | 0.040 |
Why?
|
| Buserelin | 2 | 1989 | 2 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 891 | 0.040 |
Why?
|
| Luteal Cells | 1 | 1998 | 1 | 0.040 |
Why?
|
| Calmodulin | 1 | 1997 | 8 | 0.040 |
Why?
|
| Sulfonamides | 1 | 1997 | 37 | 0.030 |
Why?
|
| In Vitro Techniques | 1 | 1997 | 175 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 1997 | 114 | 0.030 |
Why?
|
| Imidazoles | 1 | 1997 | 59 | 0.030 |
Why?
|
| Cytological Techniques | 1 | 1996 | 14 | 0.030 |
Why?
|
| Prognosis | 4 | 1993 | 785 | 0.030 |
Why?
|
| Pelvic Inflammatory Disease | 1 | 1995 | 1 | 0.030 |
Why?
|
| Pregnancy Rate | 1 | 1995 | 1 | 0.030 |
Why?
|
| Ascitic Fluid | 1 | 1995 | 10 | 0.030 |
Why?
|
| Karyotyping | 2 | 1993 | 11 | 0.030 |
Why?
|
| Follicular Phase | 1 | 1995 | 2 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 1995 | 57 | 0.030 |
Why?
|
| Antigens, Tumor-Associated, Carbohydrate | 1 | 1994 | 2 | 0.030 |
Why?
|
| Life Tables | 1 | 1994 | 4 | 0.030 |
Why?
|
| Catheterization | 1 | 1994 | 41 | 0.030 |
Why?
|
| Methotrexate | 1 | 1994 | 38 | 0.030 |
Why?
|
| Mice, Inbred Strains | 3 | 2001 | 32 | 0.030 |
Why?
|
| Contraceptives, Oral | 1 | 1993 | 6 | 0.030 |
Why?
|
| Estrogen Replacement Therapy | 1 | 1993 | 19 | 0.030 |
Why?
|
| Embryo Implantation | 2 | 1990 | 2 | 0.030 |
Why?
|
| Menstrual Cycle | 2 | 1990 | 19 | 0.030 |
Why?
|
| Maternal Age | 1 | 1993 | 15 | 0.030 |
Why?
|
| Chromosome Disorders | 1 | 1993 | 14 | 0.030 |
Why?
|
| Gestational Age | 1 | 1993 | 89 | 0.030 |
Why?
|
| Aging | 1 | 2002 | 1544 | 0.030 |
Why?
|
| Menopause | 1 | 1993 | 101 | 0.030 |
Why?
|
| Biopsy | 1 | 1993 | 201 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 4777 | 0.020 |
Why?
|
| Random Allocation | 4 | 1999 | 124 | 0.020 |
Why?
|
| Cohort Studies | 1 | 1997 | 1890 | 0.020 |
Why?
|
| Clomiphene | 2 | 1988 | 4 | 0.020 |
Why?
|
| Injections, Subcutaneous | 1 | 1991 | 22 | 0.020 |
Why?
|
| Oligomenorrhea | 1 | 1991 | 2 | 0.020 |
Why?
|
| Pituitary Hormone-Releasing Hormones | 1 | 1988 | 1 | 0.020 |
Why?
|
| Zygote | 1 | 1988 | 2 | 0.020 |
Why?
|
| Preservation, Biological | 1 | 1988 | 4 | 0.020 |
Why?
|
| Minerals | 1 | 1988 | 6 | 0.020 |
Why?
|
| Microsurgery | 1 | 1988 | 42 | 0.020 |
Why?
|
| Ovarian Cysts | 1 | 1988 | 4 | 0.020 |
Why?
|
| Aged | 1 | 2021 | 8997 | 0.020 |
Why?
|
| Chorionic Gonadotropin, beta Subunit, Human | 1 | 1987 | 1 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 1987 | 76 | 0.020 |
Why?
|
| Bone and Bones | 1 | 1988 | 116 | 0.020 |
Why?
|
| Cell Count | 2 | 1996 | 81 | 0.020 |
Why?
|
| Luteinizing Hormone | 3 | 1989 | 12 | 0.010 |
Why?
|
| Receptors, LH | 1 | 2001 | 2 | 0.010 |
Why?
|
| CHO Cells | 1 | 2001 | 12 | 0.010 |
Why?
|
| Cricetinae | 1 | 2001 | 36 | 0.010 |
Why?
|
| Blastomeres | 1 | 2001 | 1 | 0.010 |
Why?
|
| Morula | 1 | 2001 | 1 | 0.010 |
Why?
|
| Embryonic Development | 1 | 2001 | 7 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2001 | 107 | 0.010 |
Why?
|
| Reference Values | 1 | 2001 | 186 | 0.010 |
Why?
|
| Cardiolipins | 1 | 1999 | 2 | 0.010 |
Why?
|
| Antigens, Nuclear | 1 | 1999 | 4 | 0.010 |
Why?
|
| Blood Donors | 1 | 1999 | 5 | 0.010 |
Why?
|
| Causality | 1 | 1999 | 56 | 0.010 |
Why?
|
| Thyroid Gland | 1 | 1999 | 43 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 1999 | 89 | 0.010 |
Why?
|
| Mitotic Index | 1 | 1998 | 6 | 0.010 |
Why?
|
| Cell Division | 1 | 1998 | 86 | 0.010 |
Why?
|
| Spindle Apparatus | 1 | 1997 | 1 | 0.010 |
Why?
|
| Adenine | 1 | 1997 | 3 | 0.010 |
Why?
|
| Chromatin | 1 | 1997 | 17 | 0.010 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1997 | 15 | 0.010 |
Why?
|
| Paclitaxel | 1 | 1997 | 50 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 1997 | 79 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 1997 | 53 | 0.010 |
Why?
|
| Rabbits | 1 | 1997 | 182 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1997 | 333 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 1997 | 366 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1996 | 143 | 0.010 |
Why?
|
| Cell Culture Techniques | 1 | 1996 | 36 | 0.010 |
Why?
|
| Cell Line | 1 | 1996 | 273 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 1996 | 139 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 1996 | 77 | 0.010 |
Why?
|
| Staining and Labeling | 1 | 1995 | 16 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1995 | 32 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 1995 | 83 | 0.010 |
Why?
|
| CA-125 Antigen | 1 | 1994 | 1 | 0.010 |
Why?
|
| Antigens, Neoplasm | 1 | 1994 | 41 | 0.010 |
Why?
|
| Glycoproteins | 1 | 1994 | 47 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 1994 | 474 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 1994 | 587 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 1992 | 520 | 0.010 |
Why?
|
| Menstruation | 1 | 1989 | 5 | 0.000 |
Why?
|
| Administration, Intranasal | 1 | 1989 | 26 | 0.000 |
Why?
|
| Depression, Chemical | 1 | 1988 | 6 | 0.000 |
Why?
|
| Antibody Formation | 1 | 1988 | 17 | 0.000 |
Why?
|
| Immunoglobulins | 1 | 1988 | 14 | 0.000 |
Why?
|
| Body Weight | 1 | 1989 | 134 | 0.000 |
Why?
|
| Amenorrhea | 1 | 1988 | 2 | 0.000 |
Why?
|
| Freezing | 1 | 1988 | 14 | 0.000 |
Why?
|
| Syndrome | 1 | 1988 | 76 | 0.000 |
Why?
|
| Laparoscopy | 1 | 1989 | 185 | 0.000 |
Why?
|
| Recurrence | 1 | 1988 | 310 | 0.000 |
Why?
|
| Risk Factors | 1 | 1992 | 2302 | 0.000 |
Why?
|